Humana New and Revised Medical Coverage Policies

December 2017 ~

Humana has released two new medical coverage policies and several updates to policies effective at the start of the New Year.

New Medical Coverage Policies

  • Molecular diagnostic testing for vaginitis and sexually transmitted infections
  • Recurrent pregnancy loss

Medical Coverage Policies with Significant Revisions

  • Achalasia and gastroesophageal reflux disease (GERD) treatments Effective 1/1/18
  • Breast reconstruction
  • Chiropractic care
  • Cochlear implants, auditory brainstem implants Effective 1/1/18
  • Comparative genomic hybridization/chromosomal microarray analysis
  • Fecal microbiota transplantation (FMT)
  • Fusion imaging
  • Gastric pacing
  • Gastrointestinal (GI) motility monitoring
  • Genetic testing for hereditary hemochromatosis
  • Genetic testing for muscular dystrophy and spinal muscular atrophy
  • Implantable infusion pumps for pain or spasticity Effective 1/1/18
  • Infertility evaluation and treatments
  • Intra-operative neurological monitoring
  • Lymphedema – diagnosis and treatment
  • Mobility assistive devices (wheelchairs) Effective 1/1/18
  • Noninvasive prenatal screening
  • Osteochondral defects surgery
  • Pharmacogenomics and companion diagnostics
  • Platelet-derived growth factors for wound healing
  • Pneumatic compression pumps
  • Rheumatoid arthritis: biologic markers and pharmacologic assessment
  • Rhinoplasty/septoplasty
  • Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)

Full details on these changes can be found at Humana.com/provider by selecting “Medical and Pharmacy Coverage Policies” under “Resources.”

 

 

Source(s): YourPractice;

 

 

AdvantEdge